After being used therapeutically for thousands of years, a historic vote at the United Nations today has now finally recognised the medicinal value of cannabis.
The boy who became the figurehead of medical cannabis policy changes in the United Kingdom is set to receive his first bottle of cannabis-derived medicine on the two-year anniversary of the reforms.
Vertically integrated cannabis company Khiron Life Sciences Corp. KHRNF 12.18% has obtained certification of “Good Elaboration Practices for Magistral Preparations with Cannabis” in Colombia. This certification gives the company clearance to sell low-THC medical cannabis to the Colombian market.
Two cannabis-based medicines, used to treat epilepsy and multiple sclerosis, have been approved for use by the NHS in England.